Early ablation for heart failure patients with heart pumps or on transplant list
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether doing a catheter ablation early (before dangerous heart rhythms start) can help people with severe heart failure who need a heart transplant or already have an ICD. The goal is to see if this can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe heart failure (NYHA class III or IV) with a weak heart pump (ejection fraction 35% or less)
- You are being considered for a heart transplant
- You have an ICD or are scheduled to get one soon
- You have not had a previous ablation for heart rhythm problems
- You have not had a shock from your ICD or dangerous heart rhythm in the past
- You do not have a left ventricular assist device (heart pump)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if doing a special heart procedure (catheter ablation) at the same time as implanting a defibrillator (ICD) can prevent dangerous heart rhythms better than the ICD alone. It is for people with a very weak heart pump due to blocked arteries who are getting a first-time ICD.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
This trial tests a special pacing method (conduction system pacing) combined with a small ablation to control heart rate in people with permanent atrial fibrillation and advanced heart failure. It aims to improve symptoms and potentially avoid the need for a heart transplant or LVAD.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This trial tests a procedure to “ablate” (treat) a specific fast heart rhythm in the upper chambers of the heart that happens after previous atrial fibrillation (AF) ablation or heart surgery. It may help by stopping the rhythm and reducing symptoms, while doctors check how well the targeted mapping and ablation work.
This study tests using a new electrical pulse treatment for atrial fibrillation (AF) early on, in people who also have a type of heart failure where the heart pumps normally but is stiff. The goal is to see if this treatment helps manage both conditions better.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.